Latham & Watkins represented Amgen in the offerings, while Shearman & Sterling represented represented the underwriters. Amgen Inc. executed a senior unsecured notes offerings consisting of US$1,250,000,000 4.050%...
Amgen’s $3 Billion Senior Unsecured Notes Offerings
Inspire Medical Systems’ $247.2 Million Common Stock Offering
Latham & Watkins represented Inspire in the offering, while Shearman & Sterling advised Goldman Sachs, as sole book-running manager. Inspire Medical Systems, Inc. (NYSE: INSP) executd an...
Nkarta’s $230 Million Common Stock Offering
O’Melveny & Myers represented Nkarta, while Shearman & Sterling represented Cowen and Company, LLC, SVB Securities LLC and Evercore Group L.L.C., as representatives of the underwriters,...
AEye’s $125 Million Common Stock Purchase Agreement with Tumim Stone Capital
Shearman & Sterling represented AEye in the transaction. AEye, Inc. announced a $125 million equity line common stock purchase agreement with Tumim Stone Capital LLC (Tumim...
Aemetis’ $300 Million At-The-Market Equity Program
Shearman & Sterling represented Aemetis in the transaction. Aemetis announced the commencement of its $300 million At-The-Market equity program. Aemetis is a renewable natural gas, renewable...
Amgen’s $5 Billion Notes Offering
Shearman & Sterling represented the joint book-running managers and representatives of the underwriters in the offering. Amgen’s registered $5 billion notes offering, consisting of 1.650 percent...